USPTO Examiner DOUBRAVA JOHN A - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18806404IMAGE SPACE CONTROLLED MANUAL CATHETERAugust 2024December 2024Allow410NoNo
18381255SYRINGE SYSTEMS AND METHODS FOR MULTI-STAGE FLUID DELIVERYOctober 2023January 2025Allow1510NoNo
18227211IV ACCESS PORT CAP FOR PROVIDING ANTIMICROBIAL PROTECTIONJuly 2023December 2024Allow1610NoNo
18345746MEDICAL DEVICES FOR FLUID DELIVERY AND METHODS OF USE AND MANUFACTUREJune 2023October 2023Allow400YesNo
18338411LOW FORCE VALVES FOR DRUG DELIVERY PUMPSJune 2023June 2025Allow2320YesNo
18320769PERITONEAL DIALYSIS CAPS, SYSTEMS & METHODSMay 2023December 2023Allow710NoNo
18314082CATHETER SYSTEMS AND METHODS OF USEMay 2023November 2024Abandon1831NoNo
18140944DEVICES AND METHODS FOR DELIVERING A BENEFICIAL AGENT TO A USERApril 2023May 2025Allow2410NoNo
18138290MULTI-LUMEN MANIFOLD AND METHOD OF OPERATING A MULTI-LUMEN MANIFOLDApril 2023September 2024Abandon1730NoNo
18084020PRIMING DEVICEDecember 2022October 2024Allow2210NoNo
17986946ENDOSCOPIC MEDICAL DEVICE AND METHOD OF USENovember 2022September 2024Allow2210YesNo
18051640MEDICAL DEVICES FOR FLUID DELIVERY AND RELATED METHODS OF USENovember 2022August 2024Allow2110NoNo
17961015MEDICAMENT DELIVERY DEVICE WITH USAGE MONITORINGOctober 2022April 2025Allow3000NoNo
17937287MEDICAL DEVICES FOR FLUID DELIVERY AND METHODS OF USE AND MANUFACTURESeptember 2022June 2023Allow800NoNo
17995294LAYERED WALLS FOR RIGIDIZING DEVICESSeptember 2022March 2023Allow500NoNo
17843737FLEXIBLE CATHETERS AND RELATED METHODSJune 2022April 2023Allow1021YesNo
17703313WEARABLE PUMP ASSEMBLYMarch 2022February 2025Allow3511NoNo
17694150Bolus Delivery DeviceMarch 2022November 2023Allow2010NoNo
17684593COMMUNICATION DEVICE FOR TRANSMITTING INFORMATION FROM A MEDICAMENT DELIVERY DEVICEMarch 2022July 2025Allow4010NoNo
17673166SYRINGE SYSTEMS AND METHODS FOR MULTI-STAGE FLUID DELIVERYFebruary 2022September 2023Allow1910NoNo
17634898NEW WING PROTECTOR FOR WINGED CAPSULE AND METHOD OF USING SAMEFebruary 2022November 2022Allow910YesNo
17668990Infusion AdapterFebruary 2022November 2023Allow2110NoNo
17575601INJECTION DEVICEJanuary 2022September 2022Allow810YesNo
17575604INJECTION DEVICEJanuary 2022November 2022Allow1020YesNo
17569208Needle Hub with Pressure Interlock for Drug Delivery DeviceJanuary 2022August 2024Allow3210NoNo
17566818Medical Agent Dispensing Apparatuses, Systems, and MethodsDecember 2021April 2025Allow3910YesNo
17563669SYSTEM AND METHOD FOR LOW-PROFILE OCCLUSION BALLOON CATHETERDecember 2021November 2023Allow2210YesNo
17548971MULTI-DIRECTION STEERABLE HANDLES FOR STEERING CATHETERSDecember 2021May 2024Allow2910YesNo
17503106DRUG DELIVERY DEVICE AND METHODOctober 2021May 2025Allow4310YesNo
17498094SYRINGE SYSTEMS AND METHODS FOR MULTI-STAGE FLUID DELIVERYOctober 2021December 2023Allow2701YesNo
17600467Disposable Medical Flow-Regulating Device and SystemSeptember 2021May 2025Allow4411YesNo
17447289Systems and Methods for Automated PhacoemulsificationSeptember 2021July 2024Allow3430NoNo
17459129TRANSITIONING TO OTHER MODES IN AUTOMATED INSULIN DELIVERYAugust 2021October 2023Allow2610NoNo
17393046MEDICAL DEVICES WITH MULTI-PLANE ARTICULATIONAugust 2021February 2025Allow4241YesNo
17422498THORACIC CATHETERJuly 2021October 2024Allow3910YesNo
17374729IV ACCESS PORT CAP FOR PROVIDING ANTIMICROBIAL PROTECTIONJuly 2021April 2023Allow2110YesNo
17360180LIVESTOCK INJECTION GUN SLEEVE AND METHOD OF USEJune 2021May 2024Allow3520YesNo
17350481CATHETERJune 2021January 2025Allow4320NoNo
17312825STEERABLE SHEATH DEFLECTION MECHANISMJune 2021July 2024Allow3710NoNo
17317999INTRAVASCULAR CATHETER HAVING AN EXPANDABLE PORTIONMay 2021August 2023Allow2711NoNo
17313827System and device for irrigating and cleaning nasal cavitiesMay 2021March 2025Allow4620YesNo
17243885SHEATH RETAINER DEVICES, SYSTEMS AND METHODSApril 2021May 2023Allow2510NoNo
17223976INJECTION DEVICEApril 2021August 2021Allow501NoNo
17199246GUIDE CATHETER WITH REINFORCING MEMBERMarch 2021August 2023Allow2931NoNo
17189380SYRINGE SYSTEMS AND METHODS FOR MULTI-STAGE FLUID DELIVERYMarch 2021October 2021Allow810YesNo
17173536PERI-VASCULAR TISSUE ABLATION CATHETERSFebruary 2021December 2023Allow3410YesNo
17145078MICRODIALYSIS DEVICE COMPRISING ATTACHMENT SHEETJanuary 2021April 2023Allow2710YesNo
17114225Variable Free Tip Dialysis CatheterDecember 2020September 2024Abandon4610NoNo
17088530Dialysis CatheterNovember 2020May 2023Abandon3001NoNo
16949339Therapeutic Fluid Dispenser HolderOctober 2020May 2023Abandon3010NoNo
17072643DETECTION OF BUBBLES IN IRRIGATION FLUIDOctober 2020April 2023Allow3010NoNo
17071388GENERATING MICROBUBBLES FOR BUBBLE STUDIESOctober 2020January 2024Allow3901NoNo
17066395MULTI-DIRECTION STEERABLE HANDLESOctober 2020December 2023Allow3811NoNo
17060302BREAST PUMPOctober 2020August 2021Allow1110NoNo
17024953Vented Connector for Medical Fluid VesselsSeptember 2020January 2024Allow4010YesNo
16981888A STEERABLE CATHETERSeptember 2020October 2023Allow3710NoNo
17008147ASPIRATION SYSTEMS AND METHODS, AND EXPANDING-MOUTH CATHETERSAugust 2020September 2023Allow3610YesNo
16971581Methods, Systems and Devices for Expressing BreastmilkAugust 2020May 2024Allow4510YesNo
16944333PIPE FOR FLUID SUPPLY AND AIR FEEDING SYSTEM INCLUDING PIPE FOR FLUID SUPPLYJuly 2020September 2024Allow5030YesNo
16963182TIGHT-BINDING DEVICE FOR MICRO-NEEDLEJuly 2020April 2023Abandon3340NoNo
16916856ENDOSCOPIC MEDICAL DEVICE AND METHOD OF USEJune 2020August 2022Allow2610YesNo
16912293DOUBLE THERMOFORM CANNULAJune 2020July 2024Allow4921YesNo
15929944MULTI-LUMEN MANIFOLD AND METHOD OF OPERATING A MULTI-LUMEN MANIFOLDMay 2020January 2023Allow3261YesNo
16871239SYRINGE WITH DUAL NESTED CHAMBERS AND METHOD OF USEMay 2020August 2023Allow3901NoNo
16869258ADMINISTRATION SYSTEM FOR ADMINISTERING A MEDICAL TREATMENT LIQUID TO A PATIENT AND EQUIPPED WITH A PURGE TUBINGMay 2020August 2023Abandon4030NoNo
16867132System and Methods for Left Atrial AccessMay 2020February 2025Abandon5740YesNo
16847297MEDICAMENT DELIVERY DEVICE WITH USAGE MONITORINGApril 2020April 2023Allow3610YesNo
16841809BALLOON CATHETER WITH ADJUSTABLE SHEATHApril 2020May 2025Abandon6041YesNo
16753979REINFORCED SHEATH FOR A STEERABLE SHEATH ASSEMBLYApril 2020September 2021Allow1710YesNo
16831065MEDICAL FLUID CONNECTORMarch 2020February 2022Allow2300YesNo
16819274DEVICE AND METHOD FOR THE ADJUSTMENT OF TEMPERATUREMarch 2020August 2024Abandon5321NoNo
16816458DEVICES AND METHODS FOR DELIVERING A BENEFICIAL AGENT TO A USERMarch 2020January 2023Allow3510YesNo
16793290ELECTRONIC CONTROL OF MEDICAL DEVICE DEPLOYMENT SYSTEMS AND METHODSFebruary 2020June 2024Allow5260YesNo
16793967IV CATHETER WITH INTEGRAL EXTENSION SET AND A SPRING POWERED NEEDLE SAFETYFebruary 2020June 2024Abandon5280YesNo
16787310Angular Cap for Dispensing LiquidsFebruary 2020April 2023Allow3820YesNo
16738735OPHTHALMIC TREATMENT SOLUTION DELIVERY DEVICES AND DELIVERY AUGMENTATION METHODSJanuary 2020November 2023Allow4620NoNo
16724435Transesophageal Catheter for Thermal Protection of the EsophagusDecember 2019January 2024Abandon4811NoNo
16719495EXPANDABLE INTRODUCER SHEATHDecember 2019April 2023Allow4020NoNo
16714821INTEGUMENTAL DISSOLVING NEEDLES AND NEEDLE DEVICESDecember 2019May 2024Abandon5380NoNo
16618583Bolus Delivery DeviceDecember 2019November 2021Allow2310YesNo
16698158Preloaded Catheter And Clot Retrieval Systems And Methods For Treatment Of Ischemic StrokeNovember 2019October 2022Abandon3410NoNo
16694090INFUSION PUMP LATCH MECHANISM AND ASSOCIATED FREE-FLOW PROTECTION DEVICENovember 2019August 2022Allow3310NoNo
16616920SAFE PEN NEEDLENovember 2019March 2021Allow1510YesNo
16611300CONICAL NEEDLE AND METHODS OF USE AND MANUFACTURINGNovember 2019July 2021Allow2130YesNo
16594450STEERABLE TUBEOctober 2019October 2024Abandon6031NoNo
16592972Implantable Drug Delivery Device with Infusate Measuring CapabilitiesOctober 2019November 2023Abandon4920NoNo
16553255CATHETERAugust 2019August 2022Allow3610NoNo
16541687CATHETER WITH MARKINGS TO FACILITATE ALIGNMENTAugust 2019April 2024Allow5640YesYes
16539497Devices and Methods for Cleaning Contaminated Body CavitiesAugust 2019January 2023Allow4110NoNo
16485396CATHETER SYSTEMAugust 2019September 2022Allow3710YesNo
16538810BONE DELIVERY APPARATUS AND METHODSAugust 2019December 2022Allow4011NoNo
16528335Adapter Assembly for Enteral FeedingJuly 2019October 2023Allow5130YesNo
16516517FEEDING SYSTEM FOR GASTRIC TUBE PATIENTSJuly 2019May 2021Allow2240NoNo
16514183LOW FORCE VALVES FOR DRUG DELIVERY PUMPSJuly 2019March 2023Allow4431YesNo
16508874Medical Device Cap for Drug Transfer AssemblyJuly 2019May 2022Allow3410NoNo
16506888DEVICE AND METHOD FOR SINGLE-NEEDLE IN VIVO ELECTROPORATIONJuly 2019January 2022Allow3010YesNo
16460978Learning Auto Phaco Phacoemulsification Mode for Ophthalmic SurgeryJuly 2019August 2023Allow5030NoNo
16459971CLOSURE FOR A MEDICAL DISPENSER INCLUDING A ONE-PIECE TIP CAPJuly 2019February 2023Allow4311YesNo
16455926Multichambered SyringeJune 2019May 2022Allow3510YesNo
16454524CATHETERJune 2019December 2022Allow4220YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner DOUBRAVA, JOHN A.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
19.1%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
9
Allowed After Appeal Filing
5
(55.6%)
Not Allowed After Appeal Filing
4
(44.4%)
Filing Benefit Percentile
85.9%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 55.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner DOUBRAVA, JOHN A - Prosecution Strategy Guide

Executive Summary

Examiner DOUBRAVA, JOHN A works in Art Unit 3783 and has examined 256 patent applications in our dataset. With an allowance rate of 80.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 37 months.

Allowance Patterns

Examiner DOUBRAVA, JOHN A's allowance rate of 80.1% places them in the 43% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by DOUBRAVA, JOHN A receive 2.05 office actions before reaching final disposition. This places the examiner in the 68% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by DOUBRAVA, JOHN A is 37 months. This places the examiner in the 15% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +24.0% benefit to allowance rate for applications examined by DOUBRAVA, JOHN A. This interview benefit is in the 74% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.7% of applications are subsequently allowed. This success rate is in the 31% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 38.6% of cases where such amendments are filed. This entry rate is in the 51% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 120.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 82% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 88.9% of appeals filed. This is in the 80% percentile among all examiners. Of these withdrawals, 50.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 9.3% are granted (fully or in part). This grant rate is in the 6% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 2.0% of allowed cases (in the 65% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.